Ann Surg Treat Res.  2021 Mar;100(3):154-165. 10.4174/astr.2021.100.3.154.

Guidelines for accreditation of endoscopy units: quality measures from the Korean Society of Coloproctology

• Shin R
• Lee S
• Han KS
• Sohn DK
• Moon SH
• Choi DH
• Kye BH
• Son HJ
• Lee SI
• Si S
• Kang WK

• KMID: 2513196
• DOI: http://doi.org/10.4174/astr.2021.100.3.154

Abstract

Purpose
Colonoscopy is an effective method of screening for colorectal cancer (CRC), and it can prevent CRC by detection and removal of precancerous lesions. The most important considerations when performing colonoscopy screening are the safety and satisfaction of the patient and the diagnostic accuracy. Accordingly, the Korean Society of Coloproctology (KSCP) herein proposes an optimal level of standard performance to be used in endoscopy units and by individual colonoscopists for screening colonoscopy. These guidelines establish specific criteria for assessment of safety and quality in screening colonoscopy.
Methods
The Colonoscopy Committee of the KSCP commissioned this Position Statement. Expert gastrointestinal surgeons representing the KSCP reviewed the published evidence to identify acceptable quality indicators and indicators that lacked sufficient evidence.
Results
The KSCP recommends an optimal standard list for quality control of screening colonoscopy in the following 6 categories: training and competency of the colonoscopist, procedural quality, facilities and equipment, performance indicators and auditable outcomes, disinfection of equipment, and sedation and recovery of the patient.
Conclusion
The KSCP recommends that endoscopy units performing CRC screening evaluate 6 key performance measures during daily practice.

Keyword

Colonoscopy; Colorectal neoplasms; Early detection of cancer; Health care quality assurance; Quality improvement

Reference

1. Stewart BW, Kleihues P. World cancer report 2003. Lyon: IARC Publications;2003.

2. Jung KW, Won YJ, Kong HJ, Lee ES. Prediction of cancer incidence and mortality in Korea, 2019. Cancer Res Treat. 2019; 51:431–437. PMID: 30913864.

3. Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015; 64:1637–1649. PMID: 26041752.

4. Bretthauer M, Kaminski MF, Løberg M, Zauber AG, Regula J, Kuipers EJ, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016; 176:894–902. PMID: 27214731.

5. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009; 150:1–8. PMID: 19075198.

6. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009; 7:770–775. PMID: 19268269.

7. Manser CN, Bachmann LM, Brunner J, Hunold F, Bauerfeind P, Marbet UA. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc. 2012; 76:110–117. PMID: 22498179.

8. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369:1095–1105. PMID: 24047059.

9. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012; 366:687–696. PMID: 22356322.

10. Sohn DK, Jeong SY, Choi HS, Lim SB, Huh JM, Kim DH, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat. 2005; 37:20–23. PMID: 19956505.

11. Burr NE, Derbyshire E, Taylor J, Whalley S, Subramanian V, Finan PJ, et al. Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population based cohort study. BMJ. 2019; 367:l6090. PMID: 31722875.

12. Cheung KS, Chen L, Seto WK, Leung WK. Epidemiology, characteristics, and survival of post-colonoscopy colorectal cancer in Asia: a population-based study. J Gastroenterol Hepatol. 2019; 34:1545–1553. PMID: 30932240.

13. Forsberg A, Hammar U, Ekbom A, Hultcrantz R. Post-colonoscopy colorectal cancers in Sweden: room for quality improvement. Eur J Gastroenterol Hepatol. 2017; 29:855–860. PMID: 28410353.

14. Murthy SK, Benchimol EI, Tinmouth J, James PD, Ducharme R, Rostom A, et al. Temporal trends in postcolonoscopy colorectal cancer rates in 50- to 74-year-old persons: a population-based study. Gastrointest Endosc. 2018; 87:1324–1334. PMID: 29317271.

15. Pedersen L, Valori R, Bernstein I, Lindorff-Larsen K, Green C, Torp-Pedersen C. Risk of post-colonoscopy colorectal cancer in Denmark: time trends and comparison with Sweden and the English National Health Service. Endoscopy. 2019; 51:733–741. PMID: 31174223.

16. Subramaniam K, Ang PW, Neeman T, Fadia M, Taupin D. Post-colonoscopy colorec t al cancers ident i f ied by probabilistic and deterministic linkage: results in an Australian prospective cohort. BMJ Open. 2019; 9:e026138.

17. Cha JM, Kim HS, Kwak MS, Park S, Park G, Kim JS, et al. Features of postcolonoscopy colorectal cancer and survival times of patients in Korea. Clin Gastroenterol Hepatol. 2019; 17:786–788. PMID: 29966709.

18. Cheung D, Evison F, Patel P, Trudgill N. Factors associated with colorectal cancer occurrence after colonoscopy that did not diagnose colorectal cancer. Gastrointest Endosc. 2016; 84:287–295. PMID: 26827612.

19. Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol. 2016; 111:1092–1101. PMID: 27296945.

20. Qadeer MA, Vargo JJ, Dumot JA, Lopez R, Trolli PA, Stevens T, et al. Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology. 2009; 136:1568–1576. PMID: 19422079.

21. Atkin W, Rogers P, Cardwell C, Cook C, Cuzick J, Wardle J, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology. 2004; 126:1247–1256. PMID: 15131784.

22. Thomas-Gibson S, Bassett P, Suzuki N, Brown GJ, Williams CB, Saunders BP. Intensive training over 5 days improves colonoscopy skills long-term. Endoscopy. 2007; 39:818–824. PMID: 17703392.

23. Han S. Achieving competence in endoscopy. ACG Case Rep J. 2019; 6:e00155. PMID: 31737697.

24. Moon HS, Choi EK, Seo JH, Moon JS, Song HJ, Kim KO, et al. Education and training guidelines for the Board of the Korean Society of Gastrointestinal Endoscopy. Clin Endosc. 2017; 50:345–356. PMID: 28783925.

25. Lee SH, Chung IK, Kim SJ, Kim JO, Ko BM, Hwangbo Y, et al. An adequate level of training for technical competence in screening and diagnostic colonoscopy: a prospective multicenter evaluation of the learning curve. Gastrointest Endosc. 2008; 67:683–689. PMID: 18279862.

26. Sedlack RE, Coyle WJ. ACE Research Group. Assessment of competency in endoscopy: establishing and validating generalizable competency benchmarks for colonoscopy. Gastrointest Endosc. 2016; 83:516–523. PMID: 26077455.

27. Oh JR, Han KS, Hong CW, Kim BC, Kim B, Park SC, et al. Colonoscopy learning curves for colorectal surgery fellow trainees: experiences with the 15-year colonoscopy training program. Ann Surg Treat Res. 2018; 95:169–174. PMID: 30310799.

28. Ward ST, Mohammed MA, Walt R, Valori R, Ismail T, Dunckley P. An analysis of the learning curve to achieve competency at colonoscopy using the JETS database. Gut. 2014; 63:1746–1754. PMID: 24470280.

29. Jones RP, Stylianides NA, Robertson AG, Yip VS, Chadwick G. National survey on endoscopy training in the UK. Ann R Coll Surg Engl. 2015; 97:386–389. PMID: 26264093.

30. Bronzwaer ME, Depla AC, van Lelyveld N, Spanier BW, Oosterhout YH, van Leerdam ME, et al. Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program. Gastrointest Endosc. 2019; 89:1–13. PMID: 30240879.

31. Singh H, Singh G. Inequities in colonoscopy: variation in performance and outcomes of colonoscopy. Gastrointest Endosc. 2009; 69:1296–1298. PMID: 19481650.

32. Chukmaitov A, Bradley CJ, Dahman B, Siangphoe U, Warren JL, Klabunde CN. Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications. Gastrointest Endosc. 2013; 77:436–446. PMID: 23290773.

33. European Colorectal Cancer Screening Guidelines Working Group. Patnick J, Segnan N, Atkin W, Halloran S, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013; 45:51–59. PMID: 23212726.

34. Guidelines for establishment of gastrointestinal endoscopy areas. Gastrointest Endosc. 1991; 37:661–662. PMID: 1756938.

35. Lee TH, Yoon JY, Paik CN, Choi HS, Jang JY. Updates on the facilities, procedures, and performance of the accredited endoscopy unit. Clin Endosc. 2019; 52:431–442. PMID: 31591280.

36. Mayhew D, Mendonca V, Murthy BV. A review of ASA physical status: historical perspectives and modern developments. Anaesthesia. 2019; 74:373–379. PMID: 30648259.

37. ASGE Standards of Practice Committee. Acosta RD, Abraham NS, Chandrasekhara V, Chathadi KV, Early DS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016; 83:3–16. PMID: 26621548.

38. Rizk MK, Sawhney MS, Cohen J, Pike IM, Adler DG, Dominitz JA, et al. Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc. 2015; 81:3–16. PMID: 25480102.

39. Zuckerman MJ, Hirota WK, Adler DG, Davila RE, Jacobson BC, Leighton JA, et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc. 2005; 61:189–194. PMID: 15729224.

40. Leslie K, Allen ML, Hessian EC, Peyton PJ, Kasza J, Courtney A, et al. Safety of sedation for gastrointestinal endoscopy in a group of university-affiliated hospitals: a prospective cohort study. Br J Anaesth. 2017; 118:90–99. PMID: 28039246.

41. Tetzlaff JE, Maurer WG. Preprocedural assessment for sedation in gastrointestinal endoscopy. Gastrointest Endosc Clin N Am. 2016; 26:433–441. PMID: 27372768.

42. Vargo JJ 2nd. Sedation-related complications in gastrointestinal endoscopy. Gastrointest Endosc Clin N Am. 2015; 25:147–158. PMID: 25442964.

43. ASGE Standards of Practice Committee. Early DS, Lightdale JR, Vargo JJ 2nd, Acosta RD, Chandrasekhara V, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018; 87:327–337. PMID: 29306520.

44. Harris ZP, Liu J, Saltzman JR. Quality assurance in the endoscopy suite: sedation and monitoring. Gastrointest Endosc Clin N Am. 2016; 26:553–562. PMID: 27372777.

45. ASGE Ensuring Safety in the Gastrointest inal Endoscopy Unit Task Force. Chapman FJ, Cohen J, Cohen LB, Collins J, et al. Guidelines for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc. 2014; 79:363–372. PMID: 24485393.

46. Yom-Tov E, Lebwohl B. Adverse events associated with colonoscopy: an examination of online concerns. BMC Gastroenterol. 2019; 19:207. PMID: 31795939.

47. Rees CJ, Bevan R, Zimmermann-Fraedrich K, Rutter MD, Rex D, Dekker E, et al. Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut. 2016; 65:2045–2060. PMID: 27802153.

48. Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2017; 49:378–397. PMID: 28268235.

49. Wong MC, Ching JY, Chan VC, Lam TY, Luk AK, Tang RS, et al. Determinants of bowel preparation quality and its association with adenoma detection: a prospective colonoscopy study). Medicine (Baltimore). 2016; 95:e2251. PMID: 26765402.

50. Baker FA, Mari A, Nafrin S, Suki M, Ovadia B, Gal O, et al. Predictors and colonoscopy outcomes of inadequate bowel cleansing: a 10-year experience in 28,725 patients. Ann Gastroenterol. 2019; 32:457–462. PMID: 31474791.

51. Rembacken B, Hassan C, Riemann JF, Chilton A, Rutter M, Dumonceau JM, et al. Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE). Endoscopy. 2012; 44:957–968. PMID: 22987217.

52. Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015; 81:31–53. PMID: 25480100.

53. Vavricka SR, Sulz MC, Degen L, Rechner R, Manz M, Biedermann L, et al. Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists. Endoscopy. 2016; 48:256–262. PMID: 26808396.

54. Lee RH, Tang RS, Muthusamy VR, Ho SB, Shah NK, Wetzel L, et al. Quality of colonoscopy withdrawal technique and variability in adenoma detection rates (with videos). Gastrointest Endosc. 2011; 74:128–134. PMID: 21531410.

55. Wierzbicki PM, Adrych K, Kartanowicz D, Stanislawowski M, Kowalczyk A, Godlewski J, et al. Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation. World J Gastroenterol. 2013; 19:4363–4373. PMID: 23885148.

56. Patel VD, Thompson WK, Lapin BR, Goldstein JL, Yen EF. Screening colonoscopy withdrawal time threshold for adequate proximal serrated polyp detection rate. Dig Dis Sci. 2018; 63:3084–3090. PMID: 29974376.

57. Patel NC, Islam RS, Wu Q, Gurudu SR, Ramirez FC, Crowell MD, et al. Measurement of polypectomy rate by using administrative claims data with validation against the adenoma detection rate. Gastrointest Endosc. 2013; 77:390–394. PMID: 23199647.

58. Williams JE, Holub JL, Faigel DO. Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc. 2012; 75:576–582. PMID: 22341104.

59. Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J. 2017; 5:309–334.

60. Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011; 140:65–72. PMID: 20854818.

61. Gingold-Belfer R, Boltin D, Sneh-Arbib O, Comaneshter D, Cohen A, Flugelman A, et al. Association between polyp detection rate and post-colonoscopy cancer among patients undergoing diagnostic colonoscopy. Clin Gastroenterol Hepatol. 2021; 19:202–204. PMID: 31712082.

62. Rees CJ, Thomas Gibson S, Rutter MD, Baragwanath P, Pullan R, Feeney M, et al. UK key performance indicators and quality assurance standards for colonoscopy. Gut. 2016; 65:1923–1929. PMID: 27531829.

63. Muscarella LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc. 2014; 6:457–474. PMID: 25324917.

64. Kovaleva J, Peters FT, van der Mei HC, Degener JE. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013; 26:231–254. PMID: 23554415.

65. ASGE Quality Assurance in Endoscopy Committee. Calderwood AH, Day LW, Muthusamy VR, Collins J, Hambrick RD 3rd, et al. ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc. 2018; 87:1167–1179. PMID: 29573782.

66. Beilenhoff U, Biering H, Blum R, Brljak J, Cimbro M, Dumonceau JM, et al. Reprocessing of flexible endoscopes and endoscopic accessories used in gastrointestinal endoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA). Update 2018. Endoscopy. 2018; 50:1205–1234. PMID: 30458567.

67. Iwakiri R, Tanaka K, Gotoda T, Oka S, Ohtsuka T, Sakata Y, et al. Guidelines for standardizing cleansing and disinfection of gastrointestinal endoscopes. Dig Endosc. 2019; 31:477–497. PMID: 31241788.

68. Reprocessing Guideline Task Force. Petersen BT, Cohen J, Hambrick RD 3rd, Buttar N, Greenwald DA, et al. Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update. Gastrointest Endosc. 2017; 85:282–294. PMID: 28069113.

69. Son BK, Kim BW, Kim WH, Myung DS, Cho YS, Jang BI, et al. Korean Society of Gastrointestinal Endoscopy Guidelines for endoscope reprocessing. Clin Endosc. 2017; 50:143–147. PMID: 28301923.

70. Mehta PP, Kochhar G, Albeldawi M, Kirsh B, Rizk M, Putka B, et al. Capnographic monitoring in routine EGD and colonoscopy with moderate sedation: a prospective, randomized, controlled trial. Am J Gastroenterol. 2016; 111:395–404. PMID: 26902229.

71. Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth. 1995; 7:89–91. PMID: 7772368.

72. Chung F. Are discharge criteria changing? J Clin Anesth. 1993; 5(6 Suppl 1):64S–68S. PMID: 8292372.

73. Rudner R, Jalowiecki P, Kawecki P, Gonciarz M, Mularczyk A, Petelenz M. Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy. Gastrointest Endosc. 2003; 57:657–663. PMID: 12709693.

74. Park HJ, Son BK, Koo HS, Kim BW. Preparation, evaluation, and recovery before and after conscious sedative endoscopy. Korean J Gastroenterol. 2017; 69:59–63. PMID: 28135792.

75. American Association for Study of Liver Diseases. American College of Gastroenterology. American Gastroenteroogical Association Institute. American Society for Gastrointestinal Endoscopy. Society for Gastroenterology Nurses and Associates. Vargo JJ, et al. Multisociety sedation curriculum for gastrointestinal endoscopy. Gastrointest Endosc. 2012; 76:e1–25. PMID: 22624793.

76. Zhang W, Zhu Z, Zheng Y. Effect and safety of propofol for sedation during colonoscopy: a meta-analysis. J Clin Anesth. 2018; 51:10–18. PMID: 30059837.

77. Sahinovic MM, Struys MM, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018; 57:1539–1558. PMID: 30019172.